CIK 2057060
GF FUND MANAGEMENT CO. LTD.
Institutional 13F holdings & portfolio
Holdings
643
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
4
Holdings
13F filings as of Dec 31, 2025 · Showing 601–643 of 643
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| TECX | Tectonic Therapeutic Inc | 367 | $1K–$15K | SH |
| RCKT | Rocket Pharmaceuticals Inc | 2K | $1K–$15K | SH |
| ALT | Altimmune Inc | 2K | $1K–$15K | SH |
| BFS | Saul Centers Inc | 224 | $1K–$15K | SH |
| AURA | Aura Biosciences Inc | 1K | $1K–$15K | SH |
| BCYC | Bicycle Therapeutics PLC | 909 | $1K–$15K | SH |
| ACRS | Aclaris Therapeutics Inc | 2K | $1K–$15K | SH |
| LRMR | Larimar Therapeutics Inc | 2K | $1K–$15K | SH |
| AVXL | Anavex Life Sciences Corp | 2K | $1K–$15K | SH |
| NGNE | Neurogene Inc | 302 | $1K–$15K | SH |
| ACIU | AC Immune SA | 2K | $1K–$15K | SH |
| CADL | Candel Therapeutics Inc | 1K | $1K–$15K | SH |
| LFCR | Lifecore Biomedical Inc | 736 | $1K–$15K | SH |
| FHTX | Foghorn Therapeutics Inc | 1K | $1K–$15K | SH |
| MENS | Jyong Biotech Ltd | 1K | $1K–$15K | SH |
| PBYI | Puma Biotechnology Inc | 989 | $1K–$15K | SH |
| NMRA | Neumora Therapeutics Inc | 3K | $1K–$15K | SH |
| ALLO | Allogene Therapeutics Inc | 4K | $1K–$15K | SH |
| SLN | Silence Therapeutics PLC | 922 | $1K–$15K | SH |
| AARD | Aardvark Therapeutics Inc | 427 | $1K–$15K | SH |
| AVIR | Atea Pharmaceuticals Inc | 2K | $1K–$15K | SH |
| OABI | OmniAb Inc | 3K | $1K–$15K | SH |
| CTNM | Contineum Therapeutics Inc | 454 | $1K–$15K | SH |
| VYGR | Voyager Therapeutics Inc | 1K | $1K–$15K | SH |
| OBIO | Orchestra BioMed Holdings Inc | 1K | $1K–$15K | SH |
| VOR | Vor BioPharma Inc | 330 | $1K–$15K | SH |
| CABA | Cabaletta Bio Inc | 2K | $1K–$15K | SH |
| QSI | Quantum-Si Inc | 4K | $1K–$15K | SH |
| TKNO | Alpha Teknova Inc | 1K | $1K–$15K | SH |
| EDIT | Editas Medicine Inc | 2K | $1K–$15K | SH |
| CCCC | C4 Therapeutics Inc | 2K | $1K–$15K | SH |
| SGMT | Sagimet Biosciences Inc | 608 | $1K–$15K | SH |
| ARCT | Arcturus Therapeutics Holdings | 577 | $1K–$15K | SH |
| HUMA | Humacyte Inc | 4K | $1K–$15K | SH |
| CHRS | Coherus Oncology Inc | 2K | $1K–$15K | SH |
| CRCL | Circle Internet Group Inc | 37 | $1K–$15K | SH |
| CRBU | Caribou Biosciences Inc | 2K | $1K–$15K | SH |
| CDXS | Codexis Inc | 2K | $1K–$15K | SH |
| UPXI | Upexi Inc | 2K | $1K–$15K | SH |
| BDTX | Black Diamond Therapeutics Inc | 1K | $1K–$15K | SH |
| RANI | Rani Therapeutics Holdings Inc | 2K | $1K–$15K | SH |
| PYXS | Pyxis Oncology Inc | 1K | $1K–$15K | SH |
| RIO | Rio Tinto PLC | 3 | <$1K | SH |